Trial record 1 of 1 for:    NCT00965458
Previous Study | Return to List | Next Study

Inducing Remission in Type 1 Diabetes With Alefacept (T1DAL)

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Immune Tolerance Network (ITN)
Information provided by (Responsible Party):
National Institute of Allergy and Infectious Diseases (NIAID)
ClinicalTrials.gov Identifier:
NCT00965458
First received: August 22, 2009
Last updated: June 6, 2013
Last verified: June 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: April 2014
  Primary Completion Date: March 2013 (Final data collection date for primary outcome measure)